Monographie - Enoxaparin sodium

Viimeisin päivitys :
29/10/2024

Enoxaparin sodium

Kemiallinen rakenne

Kauppanimi

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Bolentax	Meksiko
Clasina	Kolumbia
Clenox	Kolumbia, Marokko
Clexan	Kreikka
Clexane	Argentiina, Australia, Belgia, Brasilia, Chile, Egypti, Espanja, Etelä-Afrikka, Hollanti, Iran, Irlanti, Iso-Britannia, Japani, Kolumbia, Kroatia, Luxemburg, Marokko, Meksiko, New Zealand, Puola, Romania, Saksa, Saudi-Arabia, Sveitsi, Turkki, Venezuela, Yhdistyneet arabiemiirikunnat
Cutenox	Marokko
Dilutol	Argentiina, Ecuador
Dynalin	Intia
Enoparin	Venezuela
Enoxalon	Chile
Enoxanorth	Argentiina
Enoxatal	Kolumbia
Hemofagin	Chile
Heptron	Brasilia
Inhixa	Saksa
Klexane	Norja, Ruotsi, Suomi, Tanska
Lorapine	Argentiina
Lovenox	Itävalta, Kanada, Ranska, Yhdysvallat
Lowparin	Kolumbia
Nurox	Chile

Viitteet : Enoxaparin sodium

	tyyppi	julkaisu
311	Lehti	Newborn AL, Kessler JM, Joyner KA. Compatibility and activity of enoxaparin sodium in 0.9% sodium chloride injection for 48 hours. Am J Health-Syst Pharm 1996 ; 53: 167-169.
811	Lehti	Charland SL, Davis DD, Tillman DJ. Activity of enoxaparin sodium in tuberculin syringes for 10 days. Am J Health-Syst Pharm 1998 ; 55: 1296-1298.
1893	Lehti	Dager WE, Gosselin RC, King JF, Christensen CL, Owings JT, Larkin EC. Anti-Xa stability of diluted enoxaparin for use in pediatrics. Ann Pharmacotherapy 2004 ; 38: 569-573.
2231	Lehti	de Jongh R, Hens R, Basma V, mouton JW, Tulkens PM, Carryn S. Continuous versus intermittent infusion of temocillin, a directed spectrum penicillin for intensive care patients with nosocomial pneumonia: stability, compatibility, population pharmacokinetic studies and breakpoint selection. J Antimicrob Chemother 2008 ; 61, 2: 382-388.
3643	Laboratorio	Gentamicin sulphate (Cidomycin®) - Summary of Product Characteristics Sanofi 2015
4413	Lehti	Moffett B.S, Dinh K, Placencia J, Pelkey G, Rocky Hui S-K, Teruya J. Stability and Sterility of Enoxaparin 8 mg/mL Subcutaneous Injectable Solution. J Pediatr Pharmacol Ther 2016 ; 21, 4: 322-326.

Mentions Légales